Holdings
Sofinnova Investments, Inc.
As of Sep 30, 2026, Sofinnova Investments, Inc. reported 53 positions worth US$1.81B. Largest: Natera, Inc., Genmab A/S and Vera Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Natera, Inc. | 1.55M | US$641M | no change | Sep 30, 2026 |
| Genmab A/S | 4.35M | US$155M | +304K | Sep 30, 2026 |
| Vera Therapeutics, Inc. | 2.79M | US$90.2M | no change | Sep 30, 2026 |
| Axsome Therapeutics, Inc. | 446K | US$82.2M | +285K | Sep 30, 2026 |
| Seaport Therapeutics, Inc. | 3.56M | US$71.9M | no change | Sep 30, 2026 |
| Rapport Therapeutics, Inc. | 1.9M | US$64M | no change | Sep 30, 2026 |
| ArriVent BioPharma, Inc. | 1.7M | US$51.4M | no change | Sep 30, 2026 |
| Rhythm Pharmaceuticals, Inc. | 535K | US$50.9M | +127K | Sep 30, 2026 |
| Eli Lilly and Company | 43,777 | US$50.7M | new | Sep 30, 2026 |
| Dyne Therapeutics, Inc. | 2.51M | US$40.5M | +853K | Sep 30, 2026 |